• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸普萘洛尔口腔黏附片制剂的研发与评价:填充剂的影响

Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.

作者信息

Akbari Jafar, Nokhodchi Ali, Farid Djavad, Adrangui Massoud, Siahi-Shadbad Mohammad Reza, Saeedi Majid

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran(Sari) Medical Sciences University, Sari, Iran.

出版信息

Farmaco. 2004 Feb;59(2):155-61. doi: 10.1016/j.farmac.2003.11.011.

DOI:10.1016/j.farmac.2003.11.011
PMID:14871508
Abstract

The buccal mucosa has been investigated for local and systemic delivery of therapeutic peptides and other drugs that are subjected to first-pass metabolism or are unstable within the rest of the gastrointestinal tract. Propranolol hydrochloride (propranolol HCl) is subjected to first-pass effect, therefore formulation of buccal-adhesive dosage form can circumvent this effect. The effect of lactose (a soluble excipient) and dicalcium phosphate (DCP) (an insoluble excipient) on dissolution rate, kinetic of release and adhesion force of buccal-adhesive tablets of propranolol HCl were evaluated. Each tablet composed of 80 mg propranolol HCl, 80 mg hydroxypropylmethylcellulose (HPMC) K4M, polycarbophil AA1 and lactose or DCP with different ratios. The results showed that the presence of the fillers increased dissolution rate of the drug. The release data also showed that the effect of lactose on the dissolution rate was greater than the DCP. Kinetic release of propranolol HCl from buccal-adhesive matrices was affected by the different ratios of polymers and fillers. The fillers reduced the bioadhesion force and this effect was more considerable in formulation containing DCP. In order to determine the mode of release, the data were analyzed based on the equation Q =kt(n). The results showed that an increase in the concentration of HPMC K4M resulted in a reduction in the value of n. The value of n was not significantly affected by an increase in the concentration of lactose or DCP. The values of n in this study were calculated to be between 0.461 and 0.619, indicating both diffusional release and erosional mechanism.

摘要

颊黏膜已被用于研究治疗性肽和其他药物的局部和全身给药,这些药物会经历首过代谢或在胃肠道其他部位不稳定。盐酸普萘洛尔会经历首过效应,因此颊黏膜黏附剂型的制剂可以规避这种效应。评估了乳糖(一种可溶性辅料)和磷酸氢钙(DCP)(一种不溶性辅料)对盐酸普萘洛尔颊黏膜黏附片的溶出速率、释放动力学和黏附力的影响。每片由80mg盐酸普萘洛尔、80mg羟丙基甲基纤维素(HPMC)K4M、聚卡波非AA1和不同比例的乳糖或DCP组成。结果表明,填充剂的存在提高了药物的溶出速率。释放数据还表明,乳糖对溶出速率的影响大于DCP。盐酸普萘洛尔从颊黏膜黏附基质中的释放动力学受聚合物和填充剂不同比例的影响。填充剂降低了生物黏附力,这种效应在含有DCP的制剂中更为显著。为了确定释放模式,根据方程Q = kt(n)对数据进行分析。结果表明,HPMC K4M浓度的增加导致n值降低。n值不受乳糖或DCP浓度增加的显著影响。本研究中n值计算在0.461至0.619之间,表明既有扩散释放又有溶蚀机制。

相似文献

1
Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.盐酸普萘洛尔口腔黏附片制剂的研发与评价:填充剂的影响
Farmaco. 2004 Feb;59(2):155-61. doi: 10.1016/j.farmac.2003.11.011.
2
Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.包含在延时胶囊装置中的可侵蚀片剂的侵蚀特性。
Drug Dev Ind Pharm. 2005 Jan;31(1):79-89. doi: 10.1081/ddc-44010.
3
Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.辅料类型和用量对含羟丙甲纤维素控释片药物释放的影响研究。
Pharm Dev Technol. 2002 May;7(2):181-93. doi: 10.1081/pdt-120003486.
4
Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.老化的聚环氧乙烷长效片剂基质药物释放的比较评价:辅料和药物类型的影响。
Pharm Dev Technol. 2016 Mar;21(2):189-95. doi: 10.3109/10837450.2014.982823. Epub 2014 Nov 20.
5
Development and evaluation of a buccoadhesive propranolol tablet formulation.
Pharmazie. 1995 Jul;50(7):470-2.
6
Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.阴离子聚合物对盐酸普萘洛尔从骨架片中释放的影响。
Eur J Pharm Biopharm. 2001 Jul;52(1):75-82. doi: 10.1016/s0939-6411(01)00147-3.
7
[Preparation of buspirone hydrochloride buccal adhesive tablet and study on its drug release mechanism].盐酸丁螺环酮口腔黏附片的制备及其释药机制研究
Yao Xue Xue Bao. 2002 Aug;37(8):653-6.
8
An in vitro evaluation of fenugreek mucilage as a potential excipient for oral controlled-release matrix tablet.葫芦巴黏液作为口服控释骨架片潜在辅料的体外评价
Drug Dev Ind Pharm. 2008 Mar;34(3):323-9. doi: 10.1080/03639040701662594.
9
Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.每日一次的普萘洛尔缓释片剂型:制剂设计及体外/体内研究
Eur J Pharm Biopharm. 2004 Nov;58(3):607-14. doi: 10.1016/j.ejpb.2004.03.037.
10
Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.含高水溶性盐酸普萘洛尔的黄原胶基缓释骨架片的评估。
Acta Pol Pharm. 2013 Mar-Apr;70(2):283-9.

引用本文的文献

1
An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.聚环氧乙烷浓度和粒径对片剂基质中茶碱释放的调节作用研究
AAPS PharmSciTech. 2015 Dec;16(6):1281-9. doi: 10.1208/s12249-015-0295-z. Epub 2015 Mar 14.
2
Formulation and characterization of cetylpyridinium chloride bioadhesive tablets.十六烷基氯化吡啶生物黏附片的制剂与表征
Adv Pharm Bull. 2014 Dec;4(4):385-90. doi: 10.5681/apb.2014.057. Epub 2014 Aug 10.
3
A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff.
一种用于评估湿鼻烟中尼古丁体外释放的新型模型口腔系统。
Chem Cent J. 2013 Nov 11;7(1):176. doi: 10.1186/1752-153X-7-176.
4
The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices.酸 pH 值调节剂对亲脂-亲水基质中弱碱性药物释放特性的影响。
AAPS PharmSciTech. 2013 Dec;14(4):1341-8. doi: 10.1208/s12249-013-0019-1. Epub 2013 Aug 30.
5
Designing an extended release waxy matrix tablet containing nicardipine-hydroxy propyl β cyclodextrin complex.设计一种包含尼卡地平-羟丙基-β-环糊精包合物的缓释蜡质基质片剂。
Saudi Pharm J. 2011 Oct;19(4):245-53. doi: 10.1016/j.jsps.2011.05.004. Epub 2011 May 23.
6
Formulation variables influencing drug release from layered matrix system comprising chitosan and xanthan gum.影响由壳聚糖和黄原胶组成的层状基质系统中药物释放的制剂变量。
AAPS PharmSciTech. 2008;9(3):870-7. doi: 10.1208/s12249-008-9127-8. Epub 2008 Jul 25.